Scarica l'app Stockscreener
0.0237
0.86%
-0.0228
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GRTX Giù?
Forum
Previsione
Galera Therapeutics Inc Azioni (GRTX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi |
| Research and Development |
19.42%
6.093
|
7.561 | 7.272 |
| Interest Income/Expense |
147.44%
-2.087
|
4.399 | 4.223 |
| Operating Income/Loss |
20.30%
-13.40
|
-16.81 | -13.88 |
| Income/Loss From Continuing Operations Before Tax |
27.23%
-15.07
|
-20.71 | -17.71 |
| Income/Loss From Continuing Operations After Tax |
27.23%
-15.07
|
-20.71 | -17.71 |
Net Income/Loss
|
27.23%
-15.07
|
-20.71 | -17.71 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - |
| Attributable To Noncontrolling Interest |
-
|
- | - |
| Basic Average Shares |
5.97%
45.48
|
42.92 | 35.20 |
| Diluted Average Shares |
5.97%
45.48
|
42.92 | 35.20 |
| Basic Earnings Per Share |
31.25%
-0.33
|
-0.48 | -0.50 |
| Diluted Earnings Per Share |
168.75%
-0.33
|
0.48 | -0.50 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - |
1.21%
1.51%
Capitalizzazione:
|
Volume (24 ore):